While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...

Chairman Larry Ellison highlighted the AI's potential in the development of mRNA-based cancer vaccines. Read more here.

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

As of market close on Friday, Jan. 24, Moderna stock is up 21.6% this week. Here's why.

In a report released yesterday, Courtney Breen from Bernstein maintained a Hold rating on Moderna (MRNA – Research Report), with a price target ...

mRNA vaccine developer Moderna (MRNA) is sinking 9% after Goldman Sachs downgraded the shares to Neutral from Buy. Why Goldman Cut Its Rating on MRNA Earlier this month, Moderna reduced its 2025 ...

Earlier this month, Moderna announced business updates and progress across its pipeline. Moderna says it enters 2025 with a ...

The funding, which follows the $176 million the government awarded Moderna in June 2024, aims to get mRNA vaccines ready ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...